Resources from the same session
1316MO - BL-B01D1, a first-in-class EGFRxHER3 bispecific antibody-drug conjugate, in patients with non-small cell lung cancer: Updated results from first-in-human phase I study
Presenter: Li Zhang
Session: Mini oral session 1 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
Invited Discussant 1314MO, 1315MO and 1316MO
Presenter: Jordi Remon Masip
Session: Mini oral session 1 - NSCLC, metastatic
Resources:
Slides
Webcast